within Pharmacolibrary.Drugs.ATC.A;

model A03DA04
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 0.06,
    Cl             = 0.1,
    adminDuration  = 600,
    adminMass      = 0.02,
    adminCount     = 1,
    Vd             = 0.0015,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.0025,
    Tlag           = 600
  );

  annotation(Documentation(
    info ="<html><body><p>Ciclonium is an antispasmodic drug belonging to the class of quaternary ammonium compounds, used in combination with analgesics for the treatment of gastrointestinal spasms and related pain. It acts by inhibiting muscarinic receptors leading to smooth muscle relaxation. This ATC code refers to fixed-dose combinations of ciclonium with analgesic agents. Ciclonium is an older drug, not widely used or approved in many countries today.</p><h4>Pharmacokinetics</h4><p>No published human pharmacokinetic studies found; values below are model estimates based on the profile of similar quaternary ammonium antispasmodics administered orally in adults.</p><h4>References</h4><ol><li><p>Peltoniemi, MA, et al., &amp; Saari, TI (2016). Ketamine: A Review of Clinical Pharmacokinetics and Pharmacodynamics in Anesthesia and Pain Therapy. <i>Clinical pharmacokinetics</i> 55(9) 1059–1077. DOI:<a href=&quot;https://doi.org/10.1007/s40262-016-0383-6&quot;>10.1007/s40262-016-0383-6</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/27028535/&quot;>https://pubmed.ncbi.nlm.nih.gov/27028535</a></p></li><li><p>Moore, RA, et al., &amp; Straube, S (2015). Effects of food on pharmacokinetics of immediate release oral formulations of aspirin, dipyrone, paracetamol and NSAIDs - a systematic review. <i>British journal of clinical pharmacology</i> 80(3) 381–388. DOI:<a href=&quot;https://doi.org/10.1111/bcp.12628&quot;>10.1111/bcp.12628</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/25784216/&quot;>https://pubmed.ncbi.nlm.nih.gov/25784216</a></p></li><li><p>Lugo, RA, &amp; Kern, SE (2004). The pharmacokinetics of oxycodone. <i>Journal of pain &amp; palliative care pharmacotherapy</i> 18(4) 17–30. DOI:<a href=&quot;https://doi.org/10.1300/j354v18n04_03&quot;>10.1300/j354v18n04_03</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/15760805/&quot;>https://pubmed.ncbi.nlm.nih.gov/15760805</a></p></li></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>"
  ));
end A03DA04;
